Theranos Serves as a Cautionary Tale for Biotech Funding Post author:Sam Post published:March 15, 2018 Post category:BioPharma There are dangers in biotech funding and Theranos should serve as a warning. Source: BioSpace You Might Also Like The 2 Biotechs That Turned $8,000 Into at Least $25,600 in Just One Year June 29, 2017 Altimmune Expands to New HQ With Plans for New Jobs August 22, 2017 FDA Finally Allows 23andMe to Sell At-Home DNA Tests for 10 Diseases April 6, 2017
